Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07132541 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Saleh's Technique for Pancreaticojejunostomy (Pancreatic Parenchymal Injection of N-butyl-2-cyanoacrylate)

Study acronym: NBCA
StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Aug 25, 2026 → Nov 25, 2026
See other at-risk trials from Minia University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Aug 25, 2026 to Nov 25, 2026
    • Study completion pushed from Sep 25, 2026 to Dec 25, 2026
    v4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v3
  3. Secondary endpoints revised (5)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study investigates the safety and efficacy of injecting N-butyl-2-cyanoacrylate (Histoacryl®) into the pancreatic parenchyma during pancreaticoduodenectomy (PD) to enhance the security of the pancreaticojejunostomy (PJ) anastomosis and reduce postoperative pancreatic fistula (POPF) rates.
Trial Details
NCT Number NCT07132541
Lead Sponsor Minia University
Conditions
(from sponsor)		 Pancreaticoduodenectomy, Postoperative Pancreatic Fistula, Pancreas Cancer, Periampullary Cancer
Related terms Anastomotic Leak, Pancreatic Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov